vs
BALCHEM CORP（BCPC）与ZoomInfo Technologies Inc.（GTM）财务数据对比。点击上方公司名可切换其他公司
ZoomInfo Technologies Inc.的季度营收约是BALCHEM CORP的1.2倍（$319.1M vs $263.6M），BALCHEM CORP净利率更高（14.9% vs 10.9%，领先4.0%），BALCHEM CORP同比增速更快（9.8% vs 3.2%），过去两年BALCHEM CORP的营收复合增速更高（4.9% vs 1.4%）
Balchem Corp是一家全球特种化学品与营养原料供应商，核心业务覆盖人类营养、动物保健、制药、工业应用四大领域，为北美、欧洲、亚太等地区的客户提供定制化专用原料产品。
ZoomInfo Technologies Inc.是美国合规注册的数据服务商，通过数据采集、网页抓取等多元渠道汇总公开及非公开个人数据，同时收集企业、部门等商业主体信息，面向企业客户提供相关数据产品，助力客户开展精准营销等业务活动。
BCPC vs GTM — 直观对比
营收规模更大
GTM
是对方的1.2倍
$263.6M
营收增速更快
BCPC
高出6.6%
3.2%
净利率更高
BCPC
高出4.0%
10.9%
两年增速更快
BCPC
近两年复合增速
1.4%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $263.6M | $319.1M |
| 净利润 | $39.2M | $34.7M |
| 毛利率 | 35.6% | 84.0% |
| 营业利润率 | 19.8% | 17.0% |
| 净利率 | 14.9% | 10.9% |
| 营收同比 | 9.8% | 3.2% |
| 净利润同比 | 16.8% | 137.7% |
| 每股收益（稀释后） | $1.21 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收BCPCGTM
| Q4 25 | $263.6M | $319.1M | ||
| Q3 25 | $267.6M | $318.0M | ||
| Q2 25 | $255.5M | $306.7M | ||
| Q1 25 | $250.5M | $305.7M | ||
| Q4 24 | $240.0M | $309.1M | ||
| Q3 24 | $239.9M | $303.6M | ||
| Q2 24 | $234.1M | $291.5M | ||
| Q1 24 | $239.7M | $310.1M |
净利润BCPCGTM
| Q4 25 | $39.2M | $34.7M | ||
| Q3 25 | $40.3M | $38.7M | ||
| Q2 25 | $38.3M | $24.0M | ||
| Q1 25 | $37.1M | $26.8M | ||
| Q4 24 | $33.6M | $14.6M | ||
| Q3 24 | $33.8M | $23.8M | ||
| Q2 24 | $32.1M | $-24.4M | ||
| Q1 24 | $29.0M | $15.1M |
毛利率BCPCGTM
| Q4 25 | 35.6% | 84.0% | ||
| Q3 25 | 35.7% | 83.7% | ||
| Q2 25 | 36.4% | 83.9% | ||
| Q1 25 | 35.2% | 84.5% | ||
| Q4 24 | 36.0% | 82.8% | ||
| Q3 24 | 35.6% | 84.4% | ||
| Q2 24 | 35.5% | 84.3% | ||
| Q1 24 | 34.0% | 86.0% |
营业利润率BCPCGTM
| Q4 25 | 19.8% | 17.0% | ||
| Q3 25 | 20.4% | 21.2% | ||
| Q2 25 | 20.1% | 17.5% | ||
| Q1 25 | 20.4% | 16.5% | ||
| Q4 24 | 19.8% | 10.0% | ||
| Q3 24 | 20.0% | 14.3% | ||
| Q2 24 | 19.6% | -6.9% | ||
| Q1 24 | 17.4% | 13.9% |
净利率BCPCGTM
| Q4 25 | 14.9% | 10.9% | ||
| Q3 25 | 15.1% | 12.2% | ||
| Q2 25 | 15.0% | 7.8% | ||
| Q1 25 | 14.8% | 8.8% | ||
| Q4 24 | 14.0% | 4.7% | ||
| Q3 24 | 14.1% | 7.8% | ||
| Q2 24 | 13.7% | -8.4% | ||
| Q1 24 | 12.1% | 4.9% |
每股收益（稀释后）BCPCGTM
| Q4 25 | $1.21 | $0.11 | ||
| Q3 25 | $1.24 | $0.12 | ||
| Q2 25 | $1.17 | $0.07 | ||
| Q1 25 | $1.13 | $0.08 | ||
| Q4 24 | $1.03 | $0.04 | ||
| Q3 24 | $1.03 | $0.07 | ||
| Q2 24 | $0.98 | $-0.07 | ||
| Q1 24 | $0.89 | $0.04 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $74.6M | $179.9M |
| 总债务越低越好 | — | $1.3B |
| 股东权益账面价值 | $1.3B | $1.5B |
| 总资产 | $1.7B | $6.4B |
| 负债/权益比越低杠杆越低 | — | 0.88× |
8季度趋势，按日历期对齐
现金及短期投资BCPCGTM
| Q4 25 | $74.6M | $179.9M | ||
| Q3 25 | $65.1M | $135.0M | ||
| Q2 25 | $65.4M | $176.9M | ||
| Q1 25 | $49.9M | $140.5M | ||
| Q4 24 | $49.5M | $139.9M | ||
| Q3 24 | $73.7M | $147.7M | ||
| Q2 24 | $63.7M | $399.3M | ||
| Q1 24 | $60.3M | $440.2M |
总债务BCPCGTM
| Q4 25 | — | $1.3B | ||
| Q3 25 | — | $1.3B | ||
| Q2 25 | — | $1.3B | ||
| Q1 25 | — | $1.2B | ||
| Q4 24 | — | $1.2B | ||
| Q3 24 | — | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | — | $1.2B |
股东权益BCPCGTM
| Q4 25 | $1.3B | $1.5B | ||
| Q3 25 | $1.3B | $1.5B | ||
| Q2 25 | $1.3B | $1.6B | ||
| Q1 25 | $1.2B | $1.6B | ||
| Q4 24 | $1.1B | $1.7B | ||
| Q3 24 | $1.2B | $1.7B | ||
| Q2 24 | $1.1B | $1.9B | ||
| Q1 24 | $1.1B | $2.0B |
总资产BCPCGTM
| Q4 25 | $1.7B | $6.4B | ||
| Q3 25 | $1.7B | $6.4B | ||
| Q2 25 | $1.7B | $6.5B | ||
| Q1 25 | $1.6B | $6.4B | ||
| Q4 24 | $1.6B | $6.5B | ||
| Q3 24 | $1.6B | $6.4B | ||
| Q2 24 | $1.6B | $6.7B | ||
| Q1 24 | $1.6B | $6.8B |
负债/权益比BCPCGTM
| Q4 25 | — | 0.88× | ||
| Q3 25 | — | 0.87× | ||
| Q2 25 | — | 0.85× | ||
| Q1 25 | — | 0.75× | ||
| Q4 24 | — | 0.72× | ||
| Q3 24 | — | 0.74× | ||
| Q2 24 | — | 0.66× | ||
| Q1 24 | — | 0.61× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $67.3M | $143.5M |
| 自由现金流经营现金流 - 资本支出 | — | $127.1M |
| 自由现金流率自由现金流/营收 | — | 39.8% |
| 资本支出强度资本支出/营收 | — | 5.1% |
| 现金转化率经营现金流/净利润 | 1.72× | 4.14× |
| 过去12个月自由现金流最近4个季度 | — | $389.3M |
8季度趋势，按日历期对齐
经营现金流BCPCGTM
| Q4 25 | $67.3M | $143.5M | ||
| Q3 25 | $65.6M | $93.8M | ||
| Q2 25 | $47.3M | $108.9M | ||
| Q1 25 | $36.5M | $119.2M | ||
| Q4 24 | $52.3M | $109.0M | ||
| Q3 24 | $51.3M | $18.2M | ||
| Q2 24 | $45.0M | $126.3M | ||
| Q1 24 | $33.4M | $115.9M |
自由现金流BCPCGTM
| Q4 25 | — | $127.1M | ||
| Q3 25 | — | $70.9M | ||
| Q2 25 | — | $86.9M | ||
| Q1 25 | — | $104.4M | ||
| Q4 24 | — | $85.6M | ||
| Q3 24 | — | $600.0K | ||
| Q2 24 | — | $115.2M | ||
| Q1 24 | — | $103.1M |
自由现金流率BCPCGTM
| Q4 25 | — | 39.8% | ||
| Q3 25 | — | 22.3% | ||
| Q2 25 | — | 28.3% | ||
| Q1 25 | — | 34.2% | ||
| Q4 24 | — | 27.7% | ||
| Q3 24 | — | 0.2% | ||
| Q2 24 | — | 39.5% | ||
| Q1 24 | — | 33.2% |
资本支出强度BCPCGTM
| Q4 25 | — | 5.1% | ||
| Q3 25 | — | 7.2% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 4.8% | ||
| Q4 24 | — | 7.6% | ||
| Q3 24 | — | 5.8% | ||
| Q2 24 | — | 3.8% | ||
| Q1 24 | — | 4.1% |
现金转化率BCPCGTM
| Q4 25 | 1.72× | 4.14× | ||
| Q3 25 | 1.63× | 2.42× | ||
| Q2 25 | 1.23× | 4.54× | ||
| Q1 25 | 0.98× | 4.45× | ||
| Q4 24 | 1.56× | 7.47× | ||
| Q3 24 | 1.52× | 0.76× | ||
| Q2 24 | 1.40× | — | ||
| Q1 24 | 1.15× | 7.68× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
BCPC
| Human Nutrition And Health | $166.1M | 63% |
| Animal Nutrition And Health | $61.2M | 23% |
| Specialty Products | $34.8M | 13% |
GTM
暂无分部数据
